Shanghai Sailon Biotechnology

Shanghai Sailon Biotechnology is a leading Chinese biopharmaceutical company specializing in the research, development, and production of anti-venom and anti-toxin serums. The company is a dominant player in the domestic market, providing critical treatments for snake bites, scorpion stings, and spider bites. Beyond its core venom-related portfolio, Sailon is expanding into the development of recombinant proteins and other biological products for emergency medicine and infectious diseases. Listed on the Shanghai Stock Exchange's STAR Market, the company maintains a robust manufacturing infrastructure and a specialized R&D focus on niche life-saving therapeutics.